MedTrace Logo

Schema Focused Therapy for Chronic Depression

NCT01153867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2016-03-16

No results posted yet for this study

Summary

Schema focused therapy (SFT) is an innovative treatment approach to chronic, lifelong problems that incorporates cognitive, behavioral, experiential and psychodynamic elements and techniques. This study will determine whether SFT is a suitable and effective treatment for chronic depression in terms of acute effects and the prevention of relapse/recurrence. The secondary aim of this study is to identify the underlying mechanisms of change in SFT that lead to recovery from depression and the prevention of future relapse/recurrence.

Conditions

  • Chronic Major Depressive Disorder

Interventions

BEHAVIORAL

Schema Focused Therapy

SFT is a novel treatment approach to chronic, lifelong problems that incorporates cognitive, behavioral, experiential and psychodynamic elements and techniques. In the present study participants will receive up to 75 individual sessions of SFT depending on the individual progress in therapy.

Sponsors & Collaborators

  • Academic Community Mental Health Centre (RIAGG)

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Fritz Renner, PhD · Department of Clinical Psychological Science, Maastricht University

  • Marcus Huibers, PhD · Department of Clinical Psychological Science, Maastricht University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01153867 on ClinicalTrials.gov